These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11603915)

  • 1. Ionic or non-ionic contrast media in stent placement.
    Schräder R
    Eur Heart J; 2001 Nov; 22(21):2029-31. PubMed ID: 11603915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early hemodynamic reactions of an ionic low osmolar and a nonionic contrast medium].
    Wink K; Heinrich R
    Z Kardiol; 1984 Oct; 73(10):628-33. PubMed ID: 6516515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionic or non-ionic contrast media during coronary intervention: does it make a difference?
    Legrand V
    Eur Heart J; 2001 Mar; 22(5):353-4. PubMed ID: 11207074
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
    Persson P; Liss P; Hansell P
    J Am Coll Cardiol; 2007 Apr; 49(15):1668-1669. PubMed ID: 17433962
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and subacute stent occlusion; risk-reduction by ionic contrast media.
    Scheller B; Hennen B; Pohl A; Schieffer H; Markwirth T
    Eur Heart J; 2001 Mar; 22(5):385-91. PubMed ID: 11207080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
    Deray G
    J Am Coll Cardiol; 2007 Apr; 49(15):1668. PubMed ID: 17433961
    [No Abstract]   [Full Text] [Related]  

  • 8. Iodixanol vs ioxaglate for preventing contrast nephropathy: who is winner?
    Jo SH; Koo BK; Youn TJ; Kim HS
    Kidney Int; 2007 Apr; 71(8):828; author reply 828-9. PubMed ID: 17429424
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic effectiveness and safety of currently available X-ray contrast media].
    Sergeev PV; Sviridov NK; Poliaev IuA; Shimanovskiĭ NL
    Vestn Rentgenol Radiol; 1999; (6):45-9. PubMed ID: 10714233
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteinuria following nephroangiography. VII. Comparison between ionic monomeric, monoacidic dimeric and non-ionic contrast media in the dog.
    Törnquist C; Almén T; Golman K; Holtås S
    Acta Radiol Suppl; 1980; 362():49-52. PubMed ID: 6267893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iohexol and iopromide--two new non-ionic water-soluble radiographic contrast media: randomized, intraindividual double-blind study versus ioxaglate in peripheral angiography.
    Hagen B
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():107-14. PubMed ID: 6139064
    [No Abstract]   [Full Text] [Related]  

  • 14. Conclusion of recent 'osmolality trials' in preventing contrast-induced nephropathy by NAC--what is the standard?
    Jo SH; Koo BK; Youn TJ; Kim HS
    Nephrol Dial Transplant; 2008 Jul; 23(7):2424; author reply 2424-5. PubMed ID: 18445639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative effects on left ventricular function in coronary patients of various contrast media used in coronarography: iopamidol, diatrizoate, ioxaglate].
    Crochet D; Petitier H; de Laguerenne J; Wanlin P; Bourdon A; Grossetête R
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):758-63. PubMed ID: 6670837
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet degranulation induced by some contrast media is independent of their nonionic vs ionic nature.
    Grabowski EF; Jang IK; Gold H; Palacios IF; Boor SE; Rodino LJ; Michelson AD
    Acta Radiol Suppl; 1995; 399():182-4. PubMed ID: 8610512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse reactions following high-dose intravenous injection of urographic contrast media].
    Lackner K; Köster O; von Uexküll V; Broich H
    Rofo; 1984 Oct; 141(4):447-52. PubMed ID: 6436920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of fibrillation with isotonic contrast media for intra-arterial coronary digital subtraction angiography.
    Morris TW; Hayakawa K; Sahler LG; Ekholm S
    Diagn Imaging Clin Med; 1986; 55(3):109-13. PubMed ID: 3522039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombogenic potential of non-ionic contrast media--fact or fiction? By Rainer Schrader.
    Chronos N; Blanco J
    Eur J Radiol; 1998 Aug; 28(1):106-7. PubMed ID: 9717632
    [No Abstract]   [Full Text] [Related]  

  • 20. [New contrast media for angiography (Telebrix, Hexabrix) (author's transl)].
    Bohutová J; Kolár J; Karmazin V; Stupáková Z
    Cas Lek Cesk; 1981; 120(50):1527-30. PubMed ID: 7326714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.